Evidence map›Paper›PMID 34669015›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2022

Early response of right-ventricular function to percutaneous mitral valve repair.

Atsushi Sugiura, Jasmin Shamekhi, Tadahiro Goto, Maximilian Spieker, Christos Iliadis, Refik Kavsur, Victor Mauri, Malte Kelm, Stephan Baldus, Tetsu Tanaka and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Prognostic value of hepatorenal function following transcatheter edge-to-edge mitral valve repair.Clinical research in cardiology : official journal of the German Cardiac Society · 2021
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Atsushi Sugiura *Department of Medicine II, Heart Center Bonn, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany. Atsushi.sugiura@ukbonn.de.ORCID http://orcid.org/0000-0002-9446-9963
Jasmin Shamekhi *Department of Medicine II, Heart Center Bonn, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Tadahiro GotoDepartment of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo, Tokyo, Japan.
Maximilian SpiekerDepartment of Cardiology, Heart Center, University Hospital Düsseldorf, Düsseldorf, Germany.
Christos IliadisDepartment of Cardiology, Heart Center, University Hospital Cologne, Cologne, Germany.
Refik KavsurDepartment of Medicine II, Heart Center Bonn, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Victor MauriDepartment of Cardiology, Heart Center, University Hospital Cologne, Cologne, Germany.
Malte KelmDepartment of Cardiology, Heart Center, University Hospital Düsseldorf, Düsseldorf, Germany.
Stephan BaldusDepartment of Cardiology, Heart Center, University Hospital Cologne, Cologne, Germany.
Tetsu TanakaDepartment of Medicine II, Heart Center Bonn, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Noriaki TabataDepartment of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Jan-Malte SinningDepartment of Cardiology, St. Vinzenz-Hospital Cologne, Cologne, Germany.
Marcel WeberDepartment of Medicine II, Heart Center Bonn, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Sebastian ZimmerDepartment of Medicine II, Heart Center Bonn, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Georg NickenigDepartment of Medicine II, Heart Center Bonn, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
Ralf WestenfeldDepartment of Cardiology, Heart Center, University Hospital Düsseldorf, Düsseldorf, Germany.
Roman PfisterDepartment of Cardiology, Heart Center, University Hospital Cologne, Cologne, Germany.
Marc Ulrich BecherDepartment of Medicine II, Heart Center Bonn, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
of the Heart Failure Network Rhineland
University Hospital Bonn · DEUniversity Hospital Cologne · DEDüsseldorf University Hospital · DEKumamoto University · JPUniversity of Bonn · DEUniversity of Tokyo Health Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe change in right-ventricular function (RVF) after transcatheter mitral valve repair is still poorly understood. We assessed the early response of RVF to the MitraClip procedure and its clinical relevance.

methodsWe analyzed consecutive patients who underwent a MitraClip procedure to treat MR between August 2010 and March 2019 in the Heart Failure Network Rhineland registry. RVF was assessed before and after the procedure. Impaired RVF was defined as an RV fractional area change (RVFAC) < 35% or tricuspid annular plane systolic excursion (TAPSE) < 16 mm.

results816 eligible patients (77 ± 9 years, 58.5% male) were included in the analysis. Baseline values of RVF were: RVFAC 38.6 (IQR 29.7-46.7) % and TAPSE 17.0 (IQR 14.0-21.0) mm. At a median time of 3 (IQR 2-5) days after the procedure, the RVF remained normal in 34% (n = 274), normalized in 17% (n = 140), deteriorated in 15% (n = 125), and was persistently impaired in 34% (n = 277) of patients. The RVF response was significantly associated with a composite outcome of all-cause mortality and hospitalization due to heart failure within a 2-year follow-up. Compared to stable/normal RVF, the adjusted hazard ratios for the outcome were 1.78 (95% CI 1.10-2.86) for normalized RVF, 1.89 (95% CI 1.34-3.15) for deteriorated RVF, and 2.25 (95% CI 1.47-3.44) for persistently impaired RVF. Changes in TAPSE and RVFAC as continuous variables were significantly correlated with the outcome.

conclusionAn early change in RVF following transcatheter mitral valve repair is predictive of mortality and hospitalization due to heart failure during follow-up. Early response of RVF after MitraClip and its clinical significance. An acute, early change in RVF can be observed following the MitraClip procedure, which is associated with the risk of mortality and hospitalization for HF.

Indexed as

Heart FailureMitral Valve InsufficiencyEchocardiographyFemaleHumansMaleMitral ValveTreatment OutcomeVentricular Function, RightEchocardiographyHeart failureMitraClipPrognosisRight ventricular functionTranscatheter mitral valve repair

Identifiers

PMID34669015
PMCPMC9334433
OpenAlexW3205072527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.